Details of the Drug Formulaction

General Information of Drug Formulation (ID: F02021)

• Formulation Name: Atorvastatin 20 mg tablet
• Company: American Health Packaging; Aphena Pharma Solutions-Tennessee; Kaiser Foundation Hospitals; Legacy Pharmaceutical; State of Florida DOH Central Pharmacy; Watson Laboratories

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Atorvastatin	(DMF28YC)	Acute coronary syndrome	BA41	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Calcium carbonate	(E00198)	10112	Binding agent; Buffering agent; Diluent; Opacifying agent
Carmellose sodium	(E00625)	Not Available	Disintegrant
Lactose monohydrate	(E00393)	104938	Binding agent; Diluent; Dry powder inhaler carrier; Lyophilization aid
Magnesium stearate	(E00208)	11177	lubricant
Polysorbate 80	(E00665)	Not Available	Dispersing agent; Emollient; Emulsifying agent; Plasticizing agent; Solubilizing agent; Surfactant; Suspending agent
Talc	(E00520)	16211421	Anticaking agent; Diluent; Glidant; lubricant
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent